Research Article
Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma
Figure 3
Prognostic analysis of the 14-signature model in the training cohort and test cohort based on the TCGA database. (a) Prognostic lymphangiogenesis-related signature construction based on LASSO Cox analysis. (b) The coefficient and log2(HR) for these prognostic lymphangiogenesis-related signatures. Kaplan–Meier curves for the OS of patients in the high- and low-risk groups in the training cohort (c) and test cohort (d).
(a) |
(b) |
(c) |
(d) |